HIMS Hims & Hers Health
- Official Name: HIMS & HERS HEALTH, INC.
- Headquarters: 2269 Chestnut St, #523, SAN FRANCISCO, CA, 94123 US
- CEO: Andrew Dudum
- Website: forhims.com
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-15 | 1 | Won by 9.612 | (0.294) - (9.906) | ||
| 2025-07-15 | 1R | Lost by 3.291 | (2.341) - 0.950 | ||
| 2025-07-22 | 2 | Lost by 2.815 | (1.878) - 0.937 | ||
| 2025-07-23 | 1R | Won by 0.624 | 12.559 - 11.935 | ||
| 2025-07-29 | 3 | Won by 13.381 TOTW | 16.305 - 2.924 | ||
| 2025-08-05 | 4 | Lost by 13.139 | (11.552) - 1.587 | ||
| 2025-08-06 | 2R | Lost by 4.909 | (4.273) - 0.636 | ||
| 2025-08-12 | 5 | Lost by 6.752 | (8.088) - (1.336) | ||
| 2025-08-19 | 6 | Lost by 6.156 | (10.111) - (3.955) | ||
| 2025-08-26 | 7 | Won by 4.868 TOTW | 7.499 - 2.631 | ||
| 2025-09-02 | 8 | Lost by 7.645 | (9.218) - (1.573) | ||
| 2025-09-09 | 9 | Won by 8.515 TOTW | 15.666 - 7.151 | ||
| 2025-09-16 | 10 | Won by 9.887 TOTW | 7.326 - (2.561) | ||
| 2025-09-23 | 11 | Won by 13.388 TOTW | 9.202 - (4.186) | ||
| 2025-09-30 | 12 | Lost by 0.874 | 1.291 - 2.165 | ||
| 2025-10-07 | 13 | Won by 2.410 | 2.146 - (0.264) | ||
| 2025-10-14 | 14 | Lost by 3.859 | (6.902) - (3.043) | ||
| 2025-10-21 | 15 | Lost by 9.882 | (7.851) - 2.031 |
Latest News
Yahoo - 2026-09-01
Hims & Hers falls after FDA crackdown on unapproved weight-loss drugs
Hims & Hers Health (NYSE:HIMS) shares fell 3.2% after the FDA warned telehealth companies and compounding pharmacies over unapproved weight-loss d...
Benzinga - 2026-09-01
FDA Says It Has Received 990 Adverse Event Reports Tied To Compounded Semaglutide And More Than 730 Tied To Compounded Tirzepatide; Establishes Import Alert For Compounded GLP-1 Active Pharmaceutical Ingredients
https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
Yahoo - 2026-09-01
Nasdaq tumbles as rising yields fuel market selloff
Rising bond yields and elevated oil prices put pressure on stocks
Yahoo - 2026-09-01
Harrow to Participate in Three Investor Conferences in September
NASHVILLE, Tenn., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North Ame...
Benzinga - 2026-09-01
How Did BONER Meme Coin Create One of Robinhood's Biggest Stories?
BONER locks up half of tokenized Hims & Hers supply on Robinhood Chain, briefly sending HIMS tokens to $132 before arbitrage restores prices.
Yahoo - 2026-08-31
Hims & Hers’ Australia Expansion Adds Growth, But Execution Will Be Key
Hims & Hers Health, Inc. (NYSE:HIMS) has entered Australia, marking its first expansion into the Asia-Pacific market. The move follows its acquisi...
Yahoo - 2026-08-31
Market Shocks Are Not Where Hims & Hers Health Stock Has Fallen Furthest
Its deepest fall inside a market shock is not its deepest fall, and that gap is what a holder should size for.
Yahoo - 2026-08-31
Hims Arrives in Australia, Bringing Personalised Care for Men Nationwide
SYDNEY, August 31, 2026--Hims & Hers, the leading global health and wellness platform, today announced it is officially launching the Hims brand i...
Yahoo - 2026-08-31
Hims Enters Australia, Marking First Expansion into the Asia-Pacific Market
SAN FRANCISCO, August 31, 2026--Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, today announced it is now ...
Yahoo - 2026-08-31
Takeda Secures FDA Approval For First-In-Class Blood Cancer Drug
On Friday, the U.S. Food and Drug Administration (FDA) approved Takeda Pharmaceutical Co. Ltd.‘s (NYSE:TAK) MIMRYLO (rusfertide) for polycythemia ve...
SeekingAlpha - 2026-08-31
Hims & Hers: A Healthcare Behemoth In The Making
Hims & Hers Health is building a vertically integrated consumer health distribution platform. Read why I am bullish about HIMS stock right now.
Yahoo - 2026-08-29
Hims & Hers Health (HIMS) Stock Looks Like A Bargain On Sales But Mixed On Broader Checks
Hims & Hers Health stock has surged over the last three years, yet recent share price setbacks and a mixed valuation score leave investors weighin...
Yahoo - 2026-08-29
MarketBeat Week in Review – 08/24 - 08/28
MarketBeat analysts recap a mixed earnings week, covering AI infrastructure demand, retail's K-shaped consumer trends, Meta's $18 billion se...
Yahoo - 2026-08-29
Hims & Hers Health (HIMS) Is Down 14.6% After Raising Guidance Amid Privacy Scrutiny - What's Changed
Earlier this week, Hims & Hers Health reported quarterly revenue of US$753.2 million, up 38.2% year on year, added 307,000 customers to reach 2.89...
Yahoo - 2026-08-28
Hims & Hers (HIMS) CEO Says the FTC Doesn’t Understand His Own Company
On August 18, 2026, Hims & Hers Health, Inc. (NYSE:HIMS) CEO Andrew Dudum told CNBC that a Federal Trade Commission lawsuit over the company’s d...
Yahoo - 2026-08-28
Hims & Hers (HIMS)’ Weight-Loss Plans Results Penalties Over Visa (V) Credit Card Disputes
On August 21, 2026, Bloomberg reported that Hims & Hers Health, Inc. (NYSE:HIMS) was enrolled in Visa Inc. (NYSE:V)’s Acquirer Monitoring Progra...
Show more
Yahoo - 2026-08-27
Unpacking Q2 Earnings: Hims & Hers Health (NYSE:HIMS) In The Context Of Other Healthcare Technology Stocks
SeekingAlpha - 2026-08-27
Hims & Hers Is Growing Into Something Much Bigger
Yahoo - 2026-08-26
Curium acquisition of Lantheus backed by $5.375B of debt financing
Benzinga - 2026-08-26
Eli Lilly Announces Results From Real-World Study Of Overweight Or Obese Adults Over 55 Indicating That Staying On Zepbound For Weight Management Lowered Healthcare Costs Over Time
Yahoo - 2026-08-25
How GLP-1 Sales Could Play Out for Hims & Hers
Yahoo - 2026-08-25
Dell Stock's Massive Guidance Raise Has A Catch
Yahoo - 2026-08-25
Stocks making big moves yesterday: Funko, Hims & Hers Health, Azenta, Strategy, and RUM Group
Yahoo - 2026-08-25
Fosun Pharma Announces 2026 Interim Results
Yahoo - 2026-08-25
Hims & Hers Shares Tumble on Visa Dispute Crackdown
Yahoo - 2026-08-25
HIMS Stock Posts Worst Day In A Month As Visa Flags Disputes — But Analyst Says GLP-1 Users Are Sticking Around
Benzinga - 2026-08-24
Truist Securities Maintains Hold on Hims & Hers Health, Raises Price Target to $32
SeekingAlpha - 2026-08-21
Novo Nordisk: The Pill That Could Close The Gap With Lilly
Yahoo - 2026-08-21
HIMS Stock More Than Doubled in 6 Months: What's Driving the Rally?
Benzinga - 2026-08-21
10 Health Care Stocks Whale Activity In Today’s Session
Yahoo - 2026-08-21
Christina Lake Cannabis Announces Non-Binding Letter of Intent
Benzinga - 2026-08-21
Barclays Maintains Overweight on Hims & Hers Health, Lowers Price Target to $35
Yahoo - 2026-08-20
Hims & Hers Health (HIMS) & Novo Nordisk A/S (NVO): Two Weight-Loss Pill Players Just Got Punished for Growing Fast
Yahoo - 2026-08-20
BioSyent Releases Financial Results for Q2 and H1 2026
Benzinga - 2026-08-19
Hims & Hers Rejects Privacy Allegations While Promising Expanded Patient Access
Yahoo - 2026-08-19
Hims & Hers' Chief Accounting Officer Is Leaving. Here's What Her Latest Insider Filing Shows
Yahoo - 2026-08-19
What Long-Term Investors Should Know About This Hims Insider Filing
Yahoo - 2026-08-19
A Hims & Hers Insider Disposed of Stock as the Company Pushes Into Testosterone and Peptides. Here's What to Know
Yahoo - 2026-08-19
Hims & Hers' Policy Chief Just Filed an Insider Transaction. Here's What It Means.
SeekingAlpha - 2026-08-19
Hims & Hers: Buying The Margin Dip
Benzinga - 2026-08-19
'Novo Nordisk Starts Testing Lower-Doses of Its Wegovy Weight-Loss Pills' - WSJ
SeekingAlpha - 2026-08-18
Hims & Hers: Eucalyptus Deal Unlocks New Markets
SeekingAlpha - 2026-08-14
Hims & Hers Health's Next Act: Making Its Own Drugs Again
Yahoo - 2026-08-13
HIMS Q2 Deep Dive: AI Strategy and International Expansion Shape Telehealth Outlook
Benzinga - 2026-08-12
10 Health Care Stocks With Whale Alerts In Today’s Session
Yahoo - 2026-08-12
Hims & Hers Health (HIMS) Stock Looks Cheap Even With Legal Risk
ChartMill - 2026-08-12
AI Capex Roars On After Hours as Hormuz Stress Keeps Traders on Edge
SeekingAlpha - 2026-08-12
Hims & Hers: The Guidance Raise Doesn't Fix The Margin Problem
Yahoo - 2026-08-11
HIMS Stock Snaps 2-Day Climb: Analyst Says Record Subscriber Growth ‘Not Enough’ To Offset Margin Slide
Yahoo - 2026-08-11
Is Hims The Next Big Name In Peptides? Shares Topple Despite Sales Beat.
Yahoo - 2026-08-11
Hims & Hers Stock Plunges Post Q2 Earnings Miss, Gross Margin Down
Yahoo - 2026-08-11
Will Hims & Hers’ Higher 2026 Revenue Guidance Amid Rising Losses Change HIMS’s Investment Narrative?
Yahoo - 2026-08-11
Hims & Hers stock trims losses following quarterly results
Yahoo - 2026-08-11
Hims & Hers Q2 revenue beat offset by wider-than-expected loss
Benzinga - 2026-08-11
Citigroup Maintains Neutral on Hims & Hers Health, Lowers Price Target to $33
Yahoo - 2026-08-11
Citi Says Hims & Hers’ Full-Year Outlook Indicates ‘Hefty’ Q4 Earnings Lift, Warns Of Execution Risks
SeekingAlpha - 2026-08-11
Wall Street Lunch: Anthropic To Watermark AI-Generated Content In EU
Yahoo - 2026-08-11
HIMS Q2 Earnings Call Focuses on AI and Global Expansion
Benzinga - 2026-08-11
Deutsche Bank Maintains Hold on Hims & Hers Health, Raises Price Target to $26
Yahoo - 2026-08-11
Hims & Hers' Revenue Growth Comes at a Cost
Benzinga - 2026-08-11
B of A Securities Maintains Neutral on Hims & Hers Health, Raises Price Target to $32
Yahoo - 2026-08-11
Hims & Hers Raises Outlook as Cash Flow Weakens
Yahoo - 2026-08-11
Hims & Hers Health, Inc. Q2 2026 Earnings Call Summary
Yahoo - 2026-08-11
Hims & Hers Health Earnings: What To Look For From HIMS
Benzinga - 2026-08-11
TD Cowen Maintains Hold on Hims & Hers Health, Raises Price Target to $30
Benzinga - 2026-08-11
Morgan Stanley Maintains Equal-Weight on Hims & Hers Health, Raises Price Target to $28
Benzinga - 2026-08-11
Hims & Hers Health: Investments Necessary For Long-Term Incremental Growth, Says Bullish Analyst
Yahoo - 2026-08-11
Hims & Hers Q2 2026 earnings: loss despite revenue beat
Benzinga - 2026-08-11
Why Is Hims & Hers Health Stock Falling Tuesday?
Benzinga - 2026-08-11
OppFi Posts Downbeat Q2 Earnings, Joins Upwork, Rocket Lab And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
ChartMill - 2026-08-11
Wall Street Titans Line Up $500 Billion Behind Nvidia's AI Buildout
Benzinga - 2026-08-11
Needham Maintains Buy on Hims & Hers Health, Raises Price Target to $42
Yahoo - 2026-08-11
Hims & Hers Health Inc (HIMS) (Q2 2026) Earnings Call Highlights: Revenue Surges 40% to ...
Yahoo - 2026-08-10
Hims & Hers Health Q2 Earnings Call Highlights
Yahoo - 2026-08-10
HIMS Retail Traders Flip Bullish After Q2 Print: Hims & Hers Keeps $225M Buyback Ready For Stock ‘Disconnect’
SeekingAlpha - 2026-08-10
Hims & Hers Health, Inc. (HIMS) Q2 2026 Earnings Call Transcript
SeekingAlpha - 2026-08-10
Hims & Hers Health, Inc. 2026 Q2 - Results - Earnings Call Presentation
Yahoo - 2026-08-10
HIMS Falls 6% After Hours On Q2 Loss— Eyes Oral Testosterone And Peptides Expansion
Yahoo - 2026-08-10
Hims & Hers Health, Inc. (HIMS) Reports Q2 Loss, Tops Revenue Estimates
Benzinga - 2026-08-10
Rocket Lab USA, Hims & Hers, AST SpaceMobile, Archer Aviation and Plug Power: Why These 5 Stocks Are on Investors' Radars Today
Yahoo - 2026-08-10
Hims & Hers Lowers Profit Forecast, Shares Drop
Yahoo - 2026-08-10
Hims Stock Falls on Earnings. Why a Guidance Hike Isn’t Enough.
Yahoo - 2026-08-10
Hims & Hers shares fall after second-quarter wider-than-expected loss
Yahoo - 2026-08-10
Hims & Hers Health, Inc. Reports Second Quarter 2026 Financial Results
Benzinga - 2026-08-10
Hims & Hers Shares Drop After Mixed Q2 Earnings — Details
Benzinga - 2026-08-10
Hims & Hers Health Sees Q3 Sales $880.000M-$900.000M vs $793.071M Est
Benzinga - 2026-08-10
Hims & Hers Health Raises FY2026 Sales Guidance from $2.800B-$3.000B to $3.100B-$3.300B vs $2.928B Est
Benzinga - 2026-08-10
Hims & Hers Health Q2 EPS $(0.37) Misses $(0.03) Estimate, Sales $753.214M Beat $699.889M Estimate
Yahoo - 2026-08-10
Key Earnings Reports Ahead
Yahoo - 2026-08-10
Trading Week Awaits Inflation Reports Starting Wednesday
Yahoo - 2026-08-10
1 Healthcare Stock Worth Your Attention and 2 We Ignore
Yahoo - 2026-08-10
Stocks Mostly Up Pre-Bell as Traders Assess Middle East Developments, Await Key Inflation Data
Benzinga - 2026-08-10
Hims & Hers Stock Missed Estimates Last Quarter — Can It Turn the Page Tonight?
Benzinga - 2026-08-10
Hims & Hers Health Likely To Report Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Yahoo - 2026-08-09
SharkNinja Q2 Earnings Call Highlights
Yahoo - 2026-08-08
Eli Lilly and Company Q2 Earnings Call Highlights
Yahoo - 2026-08-08
Hims & Hers Health (HIMS) Responds To FTC Lawsuit Over Patient Data Use
Yahoo - 2026-08-07
Healthcare giant slashes key consultation fee to beat rivals
Yahoo - 2026-08-07
Can Weight-Loss Momentum Lift Hims & Hers Stock Before Q2 Earnings?
Yahoo - 2026-08-07
Claritev Corporation (CTEV) Reports Q2 Loss, Tops Revenue Estimates
Yahoo - 2026-08-06
CareCloud, Inc. (CCLD) Lags Q2 Earnings and Revenue Estimates
Yahoo - 2026-08-06
Hims & Hers Introduces New Hers App with First-of-Its-Kind, Doctor-Led, AI-Native Care Experience
Benzinga - 2026-08-06
Hims & Hers Launches Intelligent AI Care Experience, Debuting With Hers Weight Loss Members To Deliver Personalized Guidance And Real-Time Progress Monitoring
Benzinga - 2026-08-06
Amazon Pharmacy Start Delivery GLP-1 Medications To Eligible Medicare Patients For $50 Per Month
Yahoo - 2026-08-05
Clover Health Investments Q2 Earnings Call Highlights
Yahoo - 2026-08-05
Hims & Hers Health, Inc. (HIMS) Declines More Than Market: Some Information for Investors
Benzinga - 2026-08-05
CVS Health Retools Its Weight Management Program To Make It Easier For Eligible Adults To Access Clinical Care, Navigate Medication Costs And Get Ongoing Support For GLP-1 Therapy
Yahoo - 2026-08-03
1 Russell 2000 Stock with Exciting Potential and 2 We Ignore
Yahoo - 2026-08-03
Is Hims & Hers Health Stock in Trouble?
Yahoo - 2026-08-03
Bearish Pressure Is Building Around These 3 Stocks
Yahoo - 2026-07-31
San Francisco's Hims & Hers sued over health data sharing and surprise prescription charges
Yahoo - 2026-07-31
2 Growth Stocks with Explosive Upside and 1 That Underwhelm
Benzinga - 2026-07-31
Hims & Hers Shares Rebound Friday: What's Driving the Move?
Yahoo - 2026-07-30
HIMS Stock Eyes 4-Week Losing Streak: Legal Woes Fuel ‘Very High’ Uncertainty As Analyst Sticks To ‘No Moat’ Call
SeekingAlpha - 2026-07-30
Hims & Hers Health: Still An Undervalued Company With Tremendous Upside
Yahoo - 2026-07-30
FTC lawsuit: Hims & Hers shared customer data with Meta, Snap
Yahoo - 2026-07-30
Is The Sharp Drop In Hims & Hers Health Stock A Reason To Buy?
Yahoo - 2026-07-30
2 Unprofitable Stocks for Long-Term Investors and 1 We Ignore
Yahoo - 2026-07-30
Hims & Hers Health (HIMS) Faces FTC Lawsuit Over Health Data And Billing
SeekingAlpha - 2026-07-30
Hims & Hers Health: FTC Panic Gift
Benzinga - 2026-07-30
DarioHealth Launches GLP-1 Program, With Commercial Availability Expected Fall 2026, With Revenue Contribution From Late 2026 And Ramping Through 2027
Yahoo - 2026-07-29
Hims & Hers sued by FTC for sharing health data with Meta, Snap
Yahoo - 2026-07-29
FTC sues Hims & Hers, alleging it shared health data with Meta, Snap
Yahoo - 2026-07-29
Sector Update: Healthcare Stocks Softer Late Afternoon
Yahoo - 2026-07-29
FTC sues Hims & Hers over health data sharing, billing
Yahoo - 2026-07-29
Why Is HIMS Stock Down 13% Today?
Yahoo - 2026-07-29
FTC Claims Hims & Hers Charged Patients Without Consent And Shared Health Data With Big Tech
Yahoo - 2026-07-29
Hims & Hers Responds to FTC Lawsuit
Yahoo - 2026-07-29
Hims & Hers Stock Plunges After FTC Sues Over Alleged Privacy Violations
Yahoo - 2026-07-29
Sector Update: Healthcare Stocks Edge Lower in Afternoon Trading
Yahoo - 2026-07-29
US FTC sues Hims & Hers for sending user health info to Meta, Snap
Benzinga - 2026-07-29
Hims & Hers May Face FTC Lawsuit for Allegedly Sharing Sensitive User Data With Advertisers: Report
Benzinga - 2026-07-29
'US FTC suing Hims & Hers for sending user health info to Meta, Snap' - Reuters Exclusive
Benzinga - 2026-07-29
Jim Cramer: Arista Is ‘Terrific,’ Also Likes This Consumer Cyclical Stock
Yahoo - 2026-07-28
HIMS Stock Eyes Comeback After 3-Week Slide: BlackRock Raises Stake, Bulls Bet On Peptide-Fueled Q2 Run
Yahoo - 2026-07-28
Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to Note
SeekingAlpha - 2026-07-28
Understanding The AI Flywheel At Hims And Hers
Yahoo - 2026-07-27
HIMS Stock Rises Overnight: Retail Traders Bet On Peptides Upside After FDA Panel Backs 6 Of 7 Compounds
Yahoo - 2026-07-25
A Hims cofounder fired his entire marketing team for AI. Now his 24/7 online vet service is growing 20% a month
Yahoo - 2026-07-24
Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know
Yahoo - 2026-07-24
HIMS Stock Sinks as FDA Gives Hims & Hers Peptide the Cold Shoulder
Benzinga - 2026-07-24
Truist Securities Maintains Hold on Hims & Hers Health, Raises Price Target to $27
Yahoo - 2026-07-24
Is Trending Stock Hims & Hers Health, Inc. (HIMS) a Buy Now?
SeekingAlpha - 2026-07-24
Hims & Hers: Peptide Ruling A Positive, Operational Good Sense Makes 'Buy' Case (Upgrade)
Yahoo - 2026-07-24
Does FDA Peptide Shift and CAO Exit Reframe the Bull Case for Hims & Hers Health (HIMS)?
Yahoo - 2026-07-23
HIMS Stock Climbs Overnight As FDA Advisory Panel Backs 4 Peptides — ‘Pharma Bro’ Martin Shkreli Goes Short
Yahoo - 2026-07-23
Hims & Hers Health (HIMS) Gains On FDA Panel News, Is The Valuation Gap Still Wide?
Yahoo - 2026-07-23
What the FDA’s Peptide Decision Means for Hims & Hers’ Long-Term Telehealth Strategy
Yahoo - 2026-07-23
Hims & Hers Stock Pops on FDA Panel’s Peptide Recommendation
Yahoo - 2026-07-23
Why Is HIMS Stock Rallying 13% Today?
Benzinga - 2026-07-23
QUICK SPARK: Martin Shkreli Shorts Hims & Hers Stock, Says 'Peptides Are Fake Medicine'
Benzinga - 2026-07-23
Citigroup Maintains Neutral on Hims & Hers Health, Raises Price Target to $35
Benzinga - 2026-07-23
Why Is Hims & Hers Health Stock Surging on Thursday?
Yahoo - 2026-07-23
Quest Diagnostics Surges After Hims- And Oura-Tied Beat
Benzinga - 2026-07-23
FDA Advisory Panel Votes To Place BPC-157 Peptide On Allowed Pharmacy Compounding List
Benzinga - 2026-07-23
'Telehealth Firms Urge FDA to Legalize Peptides, With Guardrails' - Bloomberg
Yahoo - 2026-07-22
Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights
Yahoo - 2026-07-22
1 Cash-Producing Stock to Target This Week and 2 Facing Headwinds
Yahoo - 2026-07-22
HIMS Stock Snaps 3-Day Losing Streak: FDA Adds 8 New Peptide Voters Deemed ‘More Qualified And Less Conflicted’
Benzinga - 2026-07-21
Here’s How Much You Would Have Made Owning Hims & Hers Health Stock In The Last 5 Years
Benzinga - 2026-07-21
Novo Nordisk Takes Legal Action Against Eli Lilly To Stop Multiple Misleading National GLP-1 Advertising Campaigns
Yahoo - 2026-07-21
HIMS Stock On A 3-Day Slide: CFO Cashes Out $229K In Shares Ahead Of FDA Peptide Meeting
Yahoo - 2026-07-17
Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company
Yahoo - 2026-07-17
3 Reasons HIMS Has Explosive Upside Potential
Yahoo - 2026-07-16
This Trade Offers Two Ways To Profit From Hims & Hers Stock
Yahoo - 2026-07-13
1 Stock Under $50 with Exciting Potential and 2 Facing Challenges
Yahoo - 2026-07-13
HIMS Stock Logs Worst Week In 2 Months — Turns To Peptides Campaign Ahead Of Key FDA Meeting
SeekingAlpha - 2026-07-09
Novo Nordisk: Why I Don't Think The Story Is Broken
Benzinga - 2026-07-09
B of A Securities Maintains Neutral on Hims & Hers Health, Raises Price Target to $37
Benzinga - 2026-07-08
9 Health Care Stocks Whale Activity In Today’s Session
SeekingAlpha - 2026-07-08
Hims & Hers Health: The Market Still Doesn't Get It
Yahoo - 2026-07-07
Here's Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader Market
Yahoo - 2026-07-06
Hims & Hers (HIMS) Stock May Be Undervalued After FDA Peptide Questions
Yahoo - 2026-07-06
Hims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo - 2026-07-06
As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner
Benzinga - 2026-07-06
8 Health Care Stocks With Whale Alerts In Today’s Session
Yahoo - 2026-07-05
HIMS Stock Rises Overnight: CEO Shrugs Off Wild Swings, Bets On ‘Gold Standard’ Of Healthcare Over Next Decade
SeekingAlpha - 2026-07-03
HIMS Breakout Signals Structural Business Transformation
Yahoo - 2026-07-01
HIMS Stock Hits 2026 High After Unlocking $400M Working Capital Through JPMorgan — Retail Gets Less Bearish
Yahoo - 2026-07-01
Sector Update: Healthcare Stocks Higher Late Afternoon
Benzinga - 2026-07-01
Hims & Hers Stock Surges as Analysts Lift Price Targets
Yahoo - 2026-07-01
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
Benzinga - 2026-07-01
Hims & Hers Health’s Peptide Opportunity Tempered By FDA Recommendation, Says Analyst
Benzinga - 2026-07-01
Canaccord Genuity Maintains Buy on Hims & Hers Health, Raises Price Target to $40
Benzinga - 2026-07-01
B of A Securities Maintains Neutral on Hims & Hers Health, Raises Price Target to $36
Yahoo - 2026-07-01
HIMS Stock Slips Overnight After FDA Staff Questions Safety Of Popular Peptides — But One Analyst Says ‘This Isn’t The End’
Yahoo - 2026-06-29
Hims & Hers Health, Inc. (HIMS) Stock Falls Amid Market Uptick: What Investors Need to Know
Yahoo - 2026-06-26
OMCL or HIMS: Which Is the Better Value Stock Right Now?
SeekingAlpha - 2026-06-26
Hims & Hers: Can Fundamentals Really Support This Rebound Rally? (Downgrade)
Yahoo - 2026-06-25
HIMS Stock Eyes Big Monthly Win: Novo Nordisk Calls Hims & Hers One Of Its Most ‘Voluminous’ Telehealth Partners
SeekingAlpha - 2026-06-24
Undercovered Dozen: Blue Owl, IBM, Quantum Computing, Fiserv And More
Yahoo - 2026-06-24
Is Hims & Hers Health, Inc. (HIMS) a Top Weight Loss Stock After Barclays’ Target Increase?
Yahoo - 2026-06-23
Hims & Hers Health, Inc. (HIMS) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Benzinga - 2026-06-23
Here's How Much $100 Invested In Hims & Hers Health 5 Years Ago Would Be Worth Today
Yahoo - 2026-06-23
Hims & Hers Health (HIMS) Expands GLP 1 Offerings With Novo Nordisk Deal And Eucalyptus Buy
Yahoo - 2026-06-23
2 Unpopular Stocks That Deserve a Second Chance and 1 We Question
Yahoo - 2026-06-22
1 Surging Stock Worth Your Attention and 2 We Find Risky
Benzinga - 2026-06-22
CVS Pharmacy Announces New GLP-1 Offerings, Including Expanded Pharmacy Support And A New $49 MinuteClinic Virtual Visit That Connects Eligible Adults With Licensed Clinicians
Yahoo - 2026-06-22
HIMS Stock Slides Overnight: Insider Files Share Sale As CEO Teases Oura Wearable Integration
Yahoo - 2026-06-19
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
Yahoo - 2026-06-18
Living Longer Is Big Business. These Stocks Will Benefit.
Yahoo - 2026-06-18
Hims & Hers Rallies With a July FDA Decision Looming
Benzinga - 2026-06-18
Hims & Hers Stock Jumps After Barclays Raises Price Target
Benzinga - 2026-06-18
Barclays Maintains Overweight on Hims & Hers Health, Raises Price Target to $39
SeekingAlpha - 2026-06-18
Hims & Hers: The Bull Case Remains Strong
SeekingAlpha - 2026-06-17
Hims & Hers Health: Legal Risks Resolved With New International Growth Driver - Maintain Buy
Yahoo - 2026-06-17
HIMS Stock Gained Nearly 6% On Wednesday — Barclays Sees Breakout Potential After Novo Partnership
Yahoo - 2026-06-17
HIMS Stock Breaks Above $30 Ahead Of Upcoming FDA Peptide Review: Analysts Eye Next Growth Catalyst
Yahoo - 2026-06-16
Hims & Hers Stands to Get a Big Chunk of the $2.2B Peptides Market
SeekingAlpha - 2026-06-16
Hims & Hers Enters A New Phase
Benzinga - 2026-06-16
Hims & Hers Stock Is Climbing Tuesday: What Investors Need To Know
Yahoo - 2026-06-16
3 Market-Beating Stocks with Exciting Potential
Yahoo - 2026-06-16
HIMS Stock Logs Best Day In 2 Months: Bull Sees Peptides Driving Up To $19B In Annual Revenue By 2030
Yahoo - 2026-06-15
Hims & Hers (HIMS) Climbs 12.5% as Obesity Market Momentum Builds
Yahoo - 2026-06-15
Why Hims & Hers Health (HIMS) Is Up 11.0% After GLP-1 Weight Loss Pivot And Telehealth Deal
Yahoo - 2026-06-15
Fuel Up Your Portfolio with Suja Life’s Farm-to-Bottle Growth Strategy
Benzinga - 2026-06-15
Hims & Hers Stock Is Surging Monday: What's Driving The Move?
Yahoo - 2026-06-12
Doximity (DOCS) Up 11.2% Since Last Earnings Report: Can It Continue?
Benzinga - 2026-06-12
Hims & Hers Health Stock Slides Friday: What's Going On?
Yahoo - 2026-06-11